Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Paronychia
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Filter
Condition:
Paronychia and Granulation with Chronic Lymphocytic Leukemia
Journal:
[Rinsho ketsueki] The Japanese journal of clinical hematology
Treatment Used:
Silver Nitrate Chemical Cauterization with Ibrutinib Therapy
Number of Patients:
1
Published —
February 08, 2021
This case report describes a patient with paronychia and granulation that is undergoing ibrutinib therapy for chronic lymphocytic leukemia.
Condition:
Plexiform Neurofibroma
Journal:
BMC pediatrics
Treatment Used:
Selumetinib
Number of Patients:
3
Published —
February 07, 2021
This case report describes 3 children with plexiform neurofibroma that were treated using selumetinib.
Condition:
Nevoid Melanoma and Eruptive Nevi
Journal:
Dermatology online journal
Treatment Used:
Erlotinib
Number of Patients:
1
Published —
August 21, 2020
This case report discusses a woman with metastatic lung cancer in remission treated with erlotinib, who experienced adverse cutaneous reactions and developed eruptive nevi and a nevoid melanoma.
Condition:
Plexiform Neurofibromas (PN)
Journal:
Paediatric drugs
Treatment Used:
Selumetinib
Number of Patients:
9
Published —
June 14, 2020
This study evaluated the use of selumetinib to treat pediatric patients with inoperable plexiform neurofibromas (PN). Patients were monitored for side effects and tumor growth for an average of 12 months.
Condition:
Inoperable Plexiform Neurofibromas
Journal:
The New England journal of medicine
Treatment Used:
Selumetinib
Number of Patients:
50
Published —
March 19, 2020
This study tested the safety and efficacy of using selumetinib to treat patients with inoperable plexiform neurofibromas.
Condition:
Advanced Non-small-cell Lung Cancer
Journal:
Cancer science
Treatment Used:
Dacomitinib
Number of Patients:
81
Published —
March 12, 2020
The study researched the use of dacomitinib in treating advanced non-small cell lung cancer.
Condition:
Onychogryphosis of Hand Nails
Journal:
Joint diseases and related surgery
Treatment Used:
Total Matricectomy and Dorsal V-Y Advancement Flap
Number of Patients:
18
Published —
March 12, 2020
The study researched the outcomes of total matricectomy and dorsal V-Y advancement flap for treating onychogryphosis of hand nails.
Condition:
Fungal infections of the toenails
Journal:
The Cochrane database of systematic reviews
Treatment Used:
Topical and device-based treatments
Number of Patients:
12501
Published —
January 25, 2020
The study researched the effects of topical and device-based treatments for fungal infections of the toenails.
Condition:
Recalcitrant Trametinib-Induced Paronychia in Pediatric Patient
Journal:
Dermatologic therapy
Treatment Used:
Topical Beta Blocker Treatment, Topical Timolol
Number of Patients:
1
Published —
November 10, 2019
This case report describes the first case treated with topical timolol for a trametinib-induced paronychia in a pediatric patient that allowed to continue the third line antineoplastic therapy for his glioma.
Condition:
HER2-positive breast cancer
Journal:
Cancer chemotherapy and pharmacology
Treatment Used:
Pertuzumab and trastuzumab
Number of Patients:
48
Published —
October 24, 2019
The study researched the incidence of infections and hypogammaglobulinemia treated with the combination of pertuzumab and trastuzumab.
Condition:
Patients with EGFR Mutation-Positive Non-Small-Cell Lung Cancer (NSCLC)
Journal:
Lung cancer (Amsterdam, Netherlands)
Treatment Used:
Low Starting Dose of Afatinib as First-Line Treatment
Number of Patients:
46
Published —
August 27, 2019
This study assessed the effectiveness and safety of low starting dose of afatinib with dose modification according to its toxicity in patients with EGFR mutation-positive non-small-cell lung cancer (NSCLC).
Condition:
Korean Patients With Non-Small Cell Lung Cancer (NSCLC)
Journal:
Cancer research and treatment : official journal of Korean Cancer Association
Treatment Used:
Osimertinib
Number of Patients:
66
Published —
July 27, 2019
This study evaluated the safety and effectiveness of osimertinib in Korean patients with non-small cell lung cancer (a type of lung cancer; NSCLC).
Showing 1-12 of 25
Next